Oculis Holding AG (OCS)
Last updated: 2026-10-23 17:58:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Oculis Holding AG (OCS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $8.01, with a market capitalization of $484.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.11 to $34.48. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$484.70M | |
$8.04 | |
$34.48 | |
$6.26 | |
$8.09 | |
107.90K | |
266.64K | |
-- | |
$34.48 | |
$7.11 | |
-- | |
-- |
Oculis Holding AG (OCS) Stock Price Today
Oculis Holding AG (OCS) is currently trading at $8.01 as of 2026-10-23 17:57:00, down 0.99% ($0.08) from the previous close of $8.09
During today's regular trading session, OCS has traded between $6.26 and $34.48, with a trading volume of 107.90K shares. The current price is near the lower end of today's range.
Oculis Holding AG (OCS) 7-Day Stock Price Change
Over the past seven days, Oculis Holding AG (OCS) moved from $7.17 to $8.01, representing a gain of 11.72% ($0.84).
The stock traded between $7.11 and $8.43 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 389.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
OCS 52-Week Price Position
Position in Range: 3.3%
OCS is currently trading at $8.01, placing it 3.3% of the way from its 52-week low of $7.11 to its 52-week high of $34.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Oculis Holding AG (OCS)?
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Oculis Holding AG Information
| Employees | 67 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Oculis Holding AG (OCS) Stock on MEXC
Eligible investors can buy real shares of Oculis Holding AG (OCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Oculis Holding AG (OCS) stock price today?
2.Is OCS stock going up or down today?
3.What is OCS pre-market price?
4.What is OCS after-hours price?
5.Is OCS stock trading now?
6.Where does OCS sit relative to its 52-week high and low?
7.What sector is Oculis Holding AG in?
8.What is Oculis Holding AG's market capitalization and where is it listed?
9.How is OCS valued in terms of P/E ratio and EPS?
10.Does Oculis Holding AG pay a dividend?
Explore More US Stocks
Search Stocks
OCS Stock Calculator
Estimate the value between OCS shares and USD.
OCS Shares to USD
1.00 OCS shares = 8.01 USD
Calculations are estimates based on the latest available price and are for reference only.



